Hoon Taek Lee

Dr. Hoon Taek Lee


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2007 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
SUSang Jun Uhm
Sang Jun Uhm
MGMukesh Kumar Gupta
Mukesh Kumar Gupta
JYJi Hoon Yang
Ji Hoon Yang
SLSung‐Ho Lee
Sung‐Ho Lee
HLHoon Taek Lee
Hoon Taek Lee

1 April 2013 in Asian-Australasian Journal of Animal Sciences
Verified
Journal Article
Open access
PDF file
KLK. S. Lee
K. S. Lee
SCS.-H. Cha
S.-H. Cha
HKH. W. Kang
H. W. Kang
JSJ.-Y. Song
J.-Y. Song
Kyung-Woo LeeKyung-Woo Lee
Kyung-Woo Lee
HLHoon Taek Lee
Hoon Taek Lee
Mesenchymal stem cells (MSCs) are often known to have a therapeutic potential in the cell-mediated repair for fatal or incurable diseases. In this study, canine umbilical cord MSCs (cUC-MSCs) were isolated from umbilical cord matrix (n = 3) and subjected to proliferative culture for 5 consecutive passages. The cells at each passage were characterized for multipotent MSC properties such as proliferation kinetics, expression patterns of MSC surface markers and self-renewal associated markers, and chondrogenic differentiation. In results, the proliferation of the cells as determined by the cumulative population doubling level was observed at its peak on passage 3 and stopped after passage 5, whereas cell doubling time dramatically increased after passage 4. Expression of MSC surface markers (CD44, CD54, CD61, CD80, CD90 and Flk-1), molecule (HMGA2) and pluripotent markers (sox2, nanog) associated with self-renewal was negatively correlated with the number of passages. However, MSC surface marker (CD105) and pluripotent marker (Oct3/4) decreased with increasing the number of subpassage. cUC-MSCs at passage 1 to 5 underwent chondrogenesis under specific culture conditions, but percentage of chondrogenic differentiation decreased with increasing the number of subpassage. Collectively, the present study suggested that sequential subpassage could affect multipotent properties of cUC-MSCs and needs to be addressed before clinical applications.

1 May 2018 in Clinical Neurophysiology
Verified
Journal Article
Closed access
Sang-ku ParkSang-ku Park
Sang-ku Park
BJByung-Euk Joo
Byung-Euk Joo
SLSeunghoon Lee
Seunghoon Lee
JLJeong-A. Lee
Jeong-A. Lee
JHJeongho Hwang
Jeongho Hwang
HLHoon Taek Lee
Hoon Taek Lee

1 April 2022 in Innate Immunity
Verified
Journal Article
Open access
YKYoung Kyu Kim
Young Kyu Kim
JHJeongho Hwang
Jeongho Hwang
HLHoon Taek Lee
Hoon Taek Lee
Monocytes and macrophages that originate from common myeloid progenitors perform various crucial roles in the innate immune system. Stimulation with LPS combined with TLR4 drives the production of pro-inflammatory cytokines through MAPKs and NF-κB pathway in different cells. However, the difference in LPS susceptibility between monocytes and macrophages is poorly understood. In this study, we found that pro-inflammatory cytokines—IL-1β, IL-6 and TNFα showed greater induction in phorbol-12-myristate-13-acetate (PMA)-differentiated THP-1 cells than in THP-1 cells. To determine the difference in cytokine expression, the surface proteins such as TLR4-related proteins and intracellular adaptor proteins were more preserved in PMA-differentiated THP-1 cells than in THP-1 cells. MyD88 is a key molecule responsible for the difference in LPS susceptibility. Moreover, MAPKs and NF-κB pathway-related molecules showed higher levels of phosphorylation in PMA-differentiated THP-1 cells than in THP-1 cells. Upon MyD88 depletion, there was no difference in the phosphorylation of MAPK pathway-related molecules. Therefore, these results demonstrate that the difference in LPS susceptibility between THP-1 cells and PMA-differentiated THP-1 cells occur as a result of gap between the activated MAPKs and NF-κB pathways via changes in the expression of LPS-related receptors and MyD88.

4 December 2000 in Molecular Reproduction and Development
Verified
Journal Article
Closed access
PDF file
SUSang Jun Uhm
Sang Jun Uhm
NKNam-Hyung Kim
Nam-Hyung Kim
TKTeoan Kim
Teoan Kim
HCHyung Min Chung
Hyung Min Chung
KCKyung Hwa Chung
Kyung Hwa Chung
KCKil Saeng Chung
Kil Saeng Chung

7 July 2010 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
YJYoon Hee Jung
Yoon Hee Jung
MGMukesh Kumar Gupta
Mukesh Kumar Gupta
JSJi Young Shin
Ji Young Shin
SUSang Jun Uhm
Sang Jun Uhm
HLHoon Taek Lee
Hoon Taek Lee
The testis-derived male germ-line stem (GS) cell, the in vitro counterpart of spermatogonial stem cell (SSC), can initiate donor-derived spermatogenesis in recipient testes and therefore, has been viewed as a future therapeutic modality for treatment of male infertility in azoospermic patients and in cancer patients who are expecting chemotherapy. Upon extended in vitro culture, GS cells also generate a second cell type called multipotent adult germ-line stem (maGS) cell which, upon testicular transplantation, produces teratoma instead of initiating spermatogenesis. Here, we show that expressions of both Let-7a and Let-7d were consistently higher while that of miR-294 (embryonic stem cell-cycle-regulating miRNA; ESCC) was lower in GS cells than in maGS cells. Furthermore, among several putative targets of Let-7 identified by in silico bioinformatics, expressions of Igf2 and H19 mRNA targets significantly differed between GS and maGS cells. However, although the CTCF binding factor (a component of DNA methylation machinery at Igf2-H19 cluster) was also a putative target for Let-7, the difference in expressions of Igf2 and H19 between GS and maGS cells was not mediated through a change in DNA methylation. Both GS and maGS cells maintained androgenetic imprinting at the Igf2-H19 imprinting control region and Peg1 differentially methylated region. In conclusion, our study suggests that high Let-7 expression may be a unique property of GS cells and expressions of Let-7 and ESCC miRNAs may serve as miRNA signatures to distinguish them from maGS cells during clinical transplantation, to avoid the likelihood of teratoma formation due to maGS cells generated during extended in vitro culture of GS cells.